Active surveillance for low-risk prostate cancer

Roberta Mazzucchelli, Ioannis Nesseris, Liang Cheng, Antonio Lopez-Beltran, Rodolfo Montironi, Marina Scarpelli

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


Surgery, and radiation therapy remain the standard treatments for newly diagnosed prostate cancer patients. Nonetheless, these aggressive treatments are associated with decreased quality of life with altered sexual and urinary functions. Using modern risk stratification, several centers have gained significant experience in identifying patients with a low risk of prostate cancer progression and have adopted an active surveillance program with delayed, selective, or curative therapy. Interestingly, only limited numbers of patients under active surveillance require additional treatment. Recent data suggest that delayed treatment does not appear to alter the clinical outcome among those highly selected patients. A better understanding of the molecular determinants of prostate cancer behavior would not only enable healthcare professionals to identify which cases need aggressive treatment but, perhaps more importantly, would also indicate potential targets for the development of novel therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)3683-3692
Number of pages10
JournalAnticancer Research
Issue number9
StatePublished - Sep 2010


  • Active surveillance
  • Prostate cancer
  • Review
  • Watchful waiting

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Active surveillance for low-risk prostate cancer'. Together they form a unique fingerprint.

Cite this